Search

Your search keyword '"Nakamura, Keiji"' showing total 130 results

Search Constraints

Start Over You searched for: Author "Nakamura, Keiji" Remove constraint Author: "Nakamura, Keiji" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
130 results on '"Nakamura, Keiji"'

Search Results

7. COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production

8. Effects of phage variation on Shiga toxin 2 (Stx2) production and the virulence of Stx-producingEscherichia coli

11. Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease

12. Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan

13. Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications.

14. Author Response: Identification of key yeast species and microbe–microbe interactions impacting larval growth of Drosophila in the wild

15. Identification of key yeast species and microbe–microbe interactions impacting larval growth of Drosophila in the wild

20. Identification of Core Yeast Species and Microbe-Microbe Interactions Impacting Larval Growth of Drosophila in the Wild

21. Quantitative effect of plasma‐processed multi‐walled carbon nanotubes for mechanical property of in situ polymerized polyurethane composite.

22. Factors associated with withholding of invasive mechanical ventilation in the early phase of the COVID-19 response and their ethical analyses

23. Identification of Key Yeast Species and Microbe-Microbe Interactions Impacting Larval Growth ofDrosophilain the Wild

25. Virulence of Shigatoxigenic and Enteropathogenic Escherichia coli O80:H2 in Galleria mellonella Larvae: Comparison of the Roles of the pS88 Plasmids and STX2d Phage

27. Global population structure, genomic diversity and carbohydrate fermentation characteristics of clonal complex 119 (CC119), an understudied Shiga toxin-producing E. coli (STEC) lineage including O165:H25 and O172:H25

28. Nationwide analysis of antimicrobial resistance in pathogenic Escherichia coli strains isolated from diseased swine over 29 years in Japan

29. Alteration of a Shiga toxin-encoding phage associated with a change in toxin production level and disease severity in Escherichia coli

31. Additional file 3 of Escherichia cryptic clade I is an emerging source of human intestinal pathogens

35. A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy

39. Global population structure of the Serratia marcescens complex and identification of hospital-adapted lineages in the complex

41. Additional file 5 of Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan

43. Evaluation of isocyanate functionalization ratio on multi-walled carbon nanotubes during N2/CO2 plasma treatment.

44. Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan.

46. The global population structure and evolutionary history of the acquisition of major virulence factor-encoding genetic elements in Shiga toxin-producing Escherichia coli O121:H19

49. Infection with capsular genotype K1-ST23 hypervirulent Klebsiella pneumoniae isolates in Japan after a stay in East Asia: Two cases and a literature review

50. Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan

Catalog

Books, media, physical & digital resources